The U.S. Food and Drug Administration on Thursday authorized Merck & Co's antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving the go-ahead to a similar treatment from Pfizer Inc for high-risk patients above the age of 12.
could be promising tools for those who are sick with COVID-19, especially in the face of the fast-spreading Omicron variant, which is now dominant in the United States.
"As new variants of the virus continue to emerge, it is crucial to expand the country’s arsenal of COVID-19 therapies using emergency use authorization," said Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research. The drug is not authorized for use in patients younger than 18 because molnupiravir may affect bone and cartilage growth, the FDA said. Pfizer's drug was authorized on Wednesday for people aged 12 and older., was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to trial data.The U.S.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
U.S. FDA set to authorize Pfizer, Merck COVID-19 pills this week - Bloomberg NewsThe U.S. Food and Drug Administration is set to authorize COVID-19 treatment pills from both Pfizer Inc and Merck as early as Wednesday, Bloomberg News reported on Tuesday, citing people familiar with the matter.
Weiterlesen »
FDA authorizes 1st COVID-19 pill to protect against severe diseaseThe Food and Drug Administration on Wednesday authorized the first COVID-19 antiviral pill in the United States to protect against severe disease.
Weiterlesen »
FDA authorizes Pfizer's Covid-19 pillThe pill, called Paxlovid, will provide the U.S. with another tool to help fight the virus as the more infectious Omicron variant surges.
Weiterlesen »
FDA authorizes first pill to treat Covid-19The FDA authorizes the first pill to treat Covid-19. Pfizer's Paxlovid is meant to be taken at home before people are sick enough to be hospitalized.
Weiterlesen »
FDA Authorizes Pfizer Antiviral Pill for COVID-19The FDA was also expected to authorize an antiviral pill from Merck, but as of Wednesday afternoon, only Pfizer's had been authorized for use.
Weiterlesen »
FDA authorizes second antiviral pill to treat Covid-19The US Food and Drug Administration on Thursday authorized Merck's antiviral pill, molnupiravir, to treat Covid-19 'for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death, and for whom alternative COVID-19 treatment options authorized by the FDA are not accessible or clinically appropriate.'
Weiterlesen »